Breast Cancer Research and Treatment

, Volume 29, Issue 2, pp 141–160

Psychosocial factors in the development and progression of breast cancer

  • Leena Hilakivi-Clarke
  • Julia Rowland
  • Robert Clarke
  • Marc E. Lippman
Review

Abstract

The factors responsible for the genesis of breast cancer remain unclear. Emerging, although controversial, evidence suggests that factors related to life-style, such as dietary fat or alcohol intake, or exposure to various forms of stressors, are associated with mammary tumorigenesis. The possible role of life-style factors in breast cancer is important in light of the fact that mortality to this disease is increasing in most countries and that development of curative therapies for breast cancer has not been forthcoming. Thus, determining the role of life-style factors in the onset and progression of breast cancer, particularly among individuals genetically vulnerable to breast cancer or women with breast cancer in remission, is critical to prevent this disease. We will review the three main hypotheses which have been suggested to link psychosocial factors to the etiology of cancer, emphasizing data obtained through animal models. Interpretation of the existing data suggests that the number of stressful life-events does not predict vulnerability to develop breast cancer or survival from it; a certain level of stress appears to protect from malignancies. The crucial factor affecting tumor growth is the interaction among stress, an individual's personality, and available psychosocial support, and the effect of this interaction on an individual's ability to cope with stress. In addition, other risk factors for breast cancer known to be closely associated with psychosocial factors, namely dietary fat and alcohol consumption, may interact with the effects of psychosocial factors on breast cancer.

Key words

psychosocial factors dietary fat alcohol prevention survival 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lynch HT, Watson P, Conway TAet al.: Clinical/genetic features in hereditary breast cancer. Breast Cancer Res Treat 15: 63–71, 1990Google Scholar
  2. 2.
    Moore DH, Moore DH-II, Moore CT: Breast carcinoma ethiological factors. Adv Cancer Res 40: 189–253, 1983Google Scholar
  3. 3.
    Boyd NF, Cousins M, Lockwood Get al.: The feasibility of testing experimentally the dietary fat-breast cancer hypothesis. Br J Cancer 62: 878–881, 1990Google Scholar
  4. 4.
    Lubin JH, Burns PE, Blot WJet al.: Dietary factors and breast cancer risk. Int J Cancer 28: 685–698, 1981Google Scholar
  5. 5.
    Hiatt RA, Klatsky A, Armstrong MA: Alcohol and breast cancer. Prev Med 17: 683–685, 1988Google Scholar
  6. 6.
    Schatzkin A, Piantadosi S, Miccozzi Met al.: Alcohol consumption and breast cancer: a cross-national correlations study. Int J Epid 18: 28–31, 1989Google Scholar
  7. 7.
    Holland JC: Behavioral and psychosocial risk factors in cancer. In: Holland JC, Rowland JH (eds) Handbook of Psychooncology. Oxford University Press, New York, 1989, pp 705–726Google Scholar
  8. 8.
    Sklar LS, Anisman H: Stress and cancer. Psychol Bull 89: 369–406, 1981Google Scholar
  9. 9.
    Bloom BL, Asher SJ, White SW: Marital disruption as a stressor: A review and analysis. Psycho Bull 85: 867–894, 1978Google Scholar
  10. 10.
    Duszynski KR, Schaffer JW, Thomas CB: Neoplasms and traumatic events in childhood: Are they related? Arch Gen Psychiatry 38: 327–331, 1981Google Scholar
  11. 11.
    Fox BH: Pemorbid psychological factors as related to cancer incidence. J Behav Med 1: 45–133, 1978Google Scholar
  12. 12.
    Grossarth-Maticek R, Kanazir DT, Schmidt Pet al.: Psychological and organic variables as predictors of lung cancer, cardiac infarct and apoplexy: some differential predictors. Pers Indiv Diff 6: 313–321, 1985Google Scholar
  13. 13.
    Spiegel D, Kraemer HC, Bloom JRet al.: Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet ii: 888–891, 1989Google Scholar
  14. 14.
    Ramirez AJ, Craig TKJ, Watson JPet al.: Stress and relapse of breast cancer. Br Med J 298: 291–294, 1989Google Scholar
  15. 15.
    Jasmin C, Le MG, Marty P, Herzberg Ret al.: Evidence for a link between certain psychological factors and the risk of breast cancer in a case-control study. Ann Oncol 1: 22–29, 1990Google Scholar
  16. 16.
    Cohen S, Tyrell DAJ, Smith AP: Psychological stress and susceptibility to the common cold. New Engl J Med 325: 606–612, 1991Google Scholar
  17. 17.
    Bahnson CB: Stress and cancer: the state of the art. Psychosom 21: 975–981, 1980Google Scholar
  18. 18.
    Thomas CB, Duszynski KR: Closeness to parents and the family constellation in a prospective study of five disease states: Suicide, mental illness, malignant tumor, hypertension, and coronary heart disease. Johns Hopkins Med 134: 251–270, 1974Google Scholar
  19. 19.
    Grossarth-Maticek P, Kanazir DT, Vetter Het al.: Psychosomatic factors involved in the process of carcinogenesis. Psychotherapy Psychosom 40: 191–210, 1983Google Scholar
  20. 20.
    Cooper CL, Cooper R, Faragher B: Incidence and perception of psychosocial stress: the relationship with breast cancer. Psychol Med 19: 415–422, 1989Google Scholar
  21. 21.
    Geyer S: Life events prior to manifestation of breast cancer: a limited prospective study covering eight years before diagnosis. J Psychosom Res 35: 355–363, 1991Google Scholar
  22. 22.
    Edwards JR, Cooper CL, Pearl SGet al.: The relationship between psychosocial factors and breast cancer: some unexpected results. Behav Med Spring 16: 5–14, 1990Google Scholar
  23. 23.
    Muslin HL, Gyarfas K, Pieper WJ: Separation experience and cancer of the breast. Ann N Y Acad Sci 125: 802–806, 1966Google Scholar
  24. 24.
    Greer S, Morris T: Psychological attributes of women who develop breast cancer: a controlled study. J Psychosom Res 19: 147–153, 1975Google Scholar
  25. 25.
    Ewertz M: Bereavement and breast cancer. Br J Cancer 53: 701–703, 1986Google Scholar
  26. 26.
    Priestman TJ, Priestman SG, Bradshaw C: Stress and breast cancer. Brit J Cancer 51: 493–498, 1985Google Scholar
  27. 27.
    Miller AH, Norin JA: Neural-immune interactions. In: Miller AH (ed) Depressive Disorders & Immunity. American Psychiatric Press, Washington, DC, 1989, pp 25–49Google Scholar
  28. 28.
    Schonfield J: Psychological and life experience differences between Israeli women with benign and cancerous breast lesions. J Psychosom Res 19: 229–234, 1975Google Scholar
  29. 29.
    Solomon GF, Amkraut AA: Emotions, immunity and disease. In: Temoshok L, Van Dyke C, Legans LS (eds) Emotions in Health and Illness. Grune & Stratton, New York, 1983, pp 167–186Google Scholar
  30. 30.
    Klerman GL: Relationship between anxiety and depression. In: Roth M, Noyes JR, Burrows GD (eds) Handbook of Anxiety. Elsevier, Amsterdam, 1988, pp 59–82Google Scholar
  31. 31.
    Bieliauskas LA, Garron DC: Psychological depression and cancer. Gen Hosp Psych 4: 187–195, 1982Google Scholar
  32. 32.
    Shekelle RB, Raynor WJ, Ostfeld AMet al.: Psychological depression and 17 year risk of death from cancer. Psychosom Med 43: 117–125, 1981Google Scholar
  33. 33.
    Bieliauskas LA, Shekelle RB: Stable behaviors associated with high-point D MMPI profiles in a non-psychiatric population. J Clin Psychol 39: 422–426, 1983Google Scholar
  34. 34.
    Hahn RC, Petitti DB: Minnesota multiphasic personality inventory-rated depression and the incidence of breast cancer. Cancer 61: 845–848, 1988Google Scholar
  35. 35.
    Zonderman AB, Costa PT, McCrae RR: Depression as a risk for cancer morbidity and mortality in a nationally representative sample. JAMA 262: 1191–1195, 1989Google Scholar
  36. 36.
    Linkins RW, Comstock GW: Depressed mood and development of cancer. Am J Epidemiology 132: 962–972, 1990Google Scholar
  37. 37.
    Briand P: Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer. Anticancer Res 3: 273–282, 1983Google Scholar
  38. 38.
    Russo J, Gusterson BA, Rogers AEet al.: Comparative study of human and rat mammary tumorigenesis. Lab Invest 62: 244–278, 1990Google Scholar
  39. 39.
    Brunner N, Clarke R, Lippman MEet al.: Models for studying the progression from hormone-dependent to hormone-independent growth in human breast cancer. In: Lippman ME, Dickson RB (eds) Growth Regulation of Cancer. Alan R Liss, New York, 1990, pp 115–125Google Scholar
  40. 40.
    Jordan CV, Lababidi MK, Langan-Fahey S: Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy. J Natl Cancer Inst 83: 492–496, 1991Google Scholar
  41. 41.
    Amkraut A, Solomon GF: Stress and murine sarcoma virus (Moloney)-induced tumors. Cancer Res 32: 1428–1433, 1972Google Scholar
  42. 42.
    Burchfield SR, Woods SC, Elich SE: Effects of cold stress on tumor growth. Physiol Behav 21: 537–540, 1978Google Scholar
  43. 43.
    Nieburgs HE, Weiss J, Navarrette Met al.: The role of stress in human and experimental oncogenesis. Cancer Detec Prev 2: 307–336, 1979Google Scholar
  44. 44.
    Newberry BH, Gildow J, Wogan Jet al.: Inhibition of Huggins tumors by forced restraint. Psychosom Med 38: 155–162, 1976Google Scholar
  45. 45.
    Newberry BL, Frankie G, Beatty PAet al.: Shock stress and DMBA-induced mammary tumors. Psychosom Med 34: 295–303, 1972Google Scholar
  46. 46.
    Pradhan SN, Ray P: Effects of stress on growth of transplanted and 7,12-dimethylbenz(a)anthracene-induced tumors and their modification by psychotropic drugs. J Nat Cancer Inst 53: 1241–1245, 1974Google Scholar
  47. 47.
    Thompson HJ, Ronan AM, Ritacco KAet al.: Effect of type and amount of dietary fat on the enhancement of rat mammary tumorigenesis by exercise. Cancer Res 49: 1904–1908, 1989Google Scholar
  48. 48.
    Tejwani GA, Gudehithlu KP, Hanissian SHet al.: Facilitation of dimethylbenz(a)anthracene-induced rat mammary tumorigenesis by restraint stress: role of β-endorphin, prolactin and naltrexone. Carcinogenesis 12: 637–641, 1991Google Scholar
  49. 49.
    Justice A: Review of the effects of stress on cancer in laboratory animals: importance of time of stress application and type of tumor. Psychol Bull 98: 108–138, 1985Google Scholar
  50. 50.
    Lewis JW, Shavit Y, Terman GWet al.: Stress and morphine affect survival of rats challenged with a mammary ascites tumor (MAT 13762B). Nat Immun Cell Growth Regul 3: 43–50, 1983Google Scholar
  51. 51.
    Riley V: Mouse mammary tumors: alteration of incidence as apparent function of stress. Science 189: 465–467, 1975Google Scholar
  52. 52.
    Giraldi T, Perissin L, Zorzet Set al.: Effects of stress on tumor growth and metastasis in mice bearing Lewis lung carcinoma. Eur J Cancer Clin Oncol 25: 1583–1588, 1989Google Scholar
  53. 53.
    Kort WJ, Weijman IM: Chronic stress and the immune response. In: Plotnikoff N, Murgo A, Faith Ret al. (eds) Stress and Immunity. CRC Press, Boca Raton, 1991, pp 523–536Google Scholar
  54. 54.
    Sklar LS, Anisman H: Stress and coping factors influence tumor growth. Science 205: 347–365, 1979Google Scholar
  55. 55.
    Kavetsky RE, Turkevich NM, Balitsky KP: On the psychophysiological mechanism of the organism's resistance to tumor growth. Ann N Y Acad Sci 125: 933–945, 1966Google Scholar
  56. 56.
    Jessop JJ, Bayer BM: Time-dependent effects of isolation on lymphocyte and adrenocortical activity. J Neuro Immun 23: 143–147, 1989Google Scholar
  57. 57.
    File SE: The rat corticosterone response: habituation and modification by chlordiazepoxide. Physiol Behav. 29: 91–95, 1982Google Scholar
  58. 58.
    Hilakivi-Clarke LA, Wright A, Lippman ME: DMBA-induced mammary tumor growth in rats exhibiting increased or decreased ability to cope with stress due to early postnatal handling or antidepressant treatment. Physiol Behav 54: 229–236, 1993Google Scholar
  59. 59.
    Levine S: Stimulation in infancy. Sci Am 202: 80–86, 1960Google Scholar
  60. 60.
    Ader R: The effects of early experience on the adrenocortical response to different magnitudes of stimulation. Physiol Behav 5: 837–839, 1970Google Scholar
  61. 61.
    Meaney MJ, Aitken DH, Bodnoff SRet al.: Early postnatal handling alters glucocorticoid receptor concentrations in selected brain regions. Behav Neurosci 99: 765–770, 1985Google Scholar
  62. 62.
    Hilakivi-Clarke LA, Turkka J, Lister RGet al.: Effects of early postnatal handling or maternal separation on betaadrenoreceptors and behaviors related to stress. Brain Res 542: 286–292, 1991Google Scholar
  63. 63.
    Fride E, Hilakivi LA, Arora PK: Neonatal handling affects immune function and behavior in Porsolt's swim test. Society for Neuroscience 20: 494.13, 1990Google Scholar
  64. 64.
    Borsini F, Lecci A, Sessarego Aet al.: Discovery of antidepressant activity by forced swimming test may depend on pre-exposure of rats to a stressful situation. Psychopharmacology 97: 183–188, 1989Google Scholar
  65. 65.
    Brandes LJ, Arron RJ, Bogdanovic RPet al.: Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res 52: 3796–3800, 1992Google Scholar
  66. 66.
    Vogel G, Neill D, Hagler Met al.: A new animal model of endogenous depression: a summary of present findings. Neurosci Biobehav Rev 14: 85–91, 1990Google Scholar
  67. 67.
    Ekbom A, Trichopoulos D, Adami HOet al.: Evidence of prenatal influences on breast cancer risk. Lancet 340: 1015–1018, 1992Google Scholar
  68. 68.
    Maunsell E, Brisson J, Deschenes L: Psychological distress after initial treatment of breast cancer. Cancer 70: 120–125, 1992Google Scholar
  69. 69.
    Dean C: Psychiatric morbidity following mastectomy: preoperative predictors and types of illness. J Psychosom Res 31: 85–92, 1987Google Scholar
  70. 70.
    Bloom JR: Psychological response to mastectomy. Cancer 59: 189–196, 1987Google Scholar
  71. 71.
    Lerman C, Rimer BK, Engstrom PF: Cancer risk notification: psychosocial and ethical implications. J Clin Oncol 9: 1275–1282, 1991Google Scholar
  72. 72.
    Levy SM, Wise BD: Psychosocial risk factors and cancer progression. Stress and Breast Cancer 2: 77–96, 1988Google Scholar
  73. 73.
    Levy SM, Herberman M, Maluish Aet al.: Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol 4: 99–113, 1985Google Scholar
  74. 74.
    Levy SM, Herberman M, Lippman Met al.: Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol 5: 348–353, 1987Google Scholar
  75. 75.
    Rowland JH: Interpersonal resources: social support. In: Holland JC, Rowland JH (eds) Handbook of Psychooncology. Oxford University Press, New York, 1989, pp 58–77Google Scholar
  76. 76.
    Levy SM, Herberman RB, Whiteside Tet al.: Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosom Med 52: 73–85, 1990Google Scholar
  77. 77.
    Barraclough J, Pinder P, Cruddas Met al.: Life events and breast cancer prognosis. Br Med J 304: 1078–1081, 1992Google Scholar
  78. 78.
    Spiegel D, Bloom J: Group therapy and hypnosis reduce metastatic pain. Psychosom Med 45: 333–339, 1983Google Scholar
  79. 79.
    Spiegel D, Bloom J, Yalom ID: Group support for patients with metastatic breast cancer. Arch Gen Psychiatry 38: 527–533, 1981Google Scholar
  80. 80.
    Greer S, Moorey S, Baruch J: Evaluation of adjuvant psychological therapy for clinically referred cancer patients. Br J Cancer 63: 257–260, 1991Google Scholar
  81. 81.
    Fawzy FI, Cousins N, Fawzy NWet al.: A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 47: 720–725, 1990Google Scholar
  82. 82.
    Edgar L, Rosberg Z, Nowlis D: Coping with cancer during the first year after diagnosis. Cancer 69: 817–828, 1992Google Scholar
  83. 83.
    Halttunen A, Hietanen P, Jallinoja Pet al.: Getting free of breast cancer. Acta Onco 3: 307–310, 1992Google Scholar
  84. 84.
    Fawzy FI, Kemeny ME, Fawzy NWet al.: A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry 47: 729–735, 1990Google Scholar
  85. 85.
    Dechambre R-P, Gosse C: Individual versus group caging of mice with grafted tumors. Cancer Res 33: 140–144, 1973Google Scholar
  86. 86.
    Sklar LS, Anisman H: Social stress influences tumor growth. Psychosom Med 42: 347–365, 1980Google Scholar
  87. 87.
    Weinberg J, Emerman JT: Effects of psychosocial stressors on mouse mammary tumor growth. Brain Behav Imm 3: 234–246, 1989Google Scholar
  88. 88.
    Brain P: What does individual housing mean to a mouse? Life Sci 16: 187–200, 1976Google Scholar
  89. 89.
    Hilakivi LA, Ota M, Lister RG: Effect of isolation on brain monoamines and behavior of mice in tests of exploration, locomotion, anxiety and behavioral despair. Pharmacol Biochem Behav 33: 371–374, 1989Google Scholar
  90. 90.
    Valzelli L: The ‘isolation syndrome’ in mice. Psychopharmacology 31: 305–320, 1973Google Scholar
  91. 91.
    LaBarba RC: Experimental and environmental factors in cancer: a review of research with animals. Psychosom Med 32: 259–276, 1970Google Scholar
  92. 92.
    Andervont HB: Influence of environment on mammary cancer in mice. J Natl Cancer Inst 4: 579–581, 1944Google Scholar
  93. 93.
    Muhlbock O: Influence of environment on the incidence of mammary tumors in mice. Acta Int Union against Cancer 7: 351, 1951Google Scholar
  94. 94.
    Lippman ME, Bolan G, Huff K: The effects of estrogens and antiestrogens on hormone responsive human breast cancer cells in long term tissue culture. Cancer Res 36: 4595–4601, 1976Google Scholar
  95. 95.
    Thomas DB: Do hormones cause breast cancer? Cancer 53: 595–604, 1984Google Scholar
  96. 96.
    Jhappan C, Stahle C, Harkins RNet al.: TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61: 1137–1146, 1990Google Scholar
  97. 97.
    Grassi L, Molinari S: Family affective climate during the childhood of adult cancer patients. J Psychosoc Oncol 4: 53–62, 1986Google Scholar
  98. 98.
    Kissen DM: Psychological factors, personality and prevention of lung cancer. Med Off 116: 135–138, 1966Google Scholar
  99. 99.
    Mastrovito RC: Personality characteristics of women with gynecological cancer. Cancer Detect Prev 2: 281–287, 1979Google Scholar
  100. 100.
    Jacobs RJ, Charles E: Life events and the occurrences of cancer in children. Psychosom Med 42: 11–24, 1980Google Scholar
  101. 101.
    Becker H: Psychodynamic aspects of breast cancer; younger and older patients. Psychother Psychosom 32: 287–296, 1979Google Scholar
  102. 102.
    Wirsching M, Hoffmann F, Stierlin Het al.: Prebioptic psychosocial characteristics of breast cancer patients. Psychother Psychosom 43: 69–76, 1985Google Scholar
  103. 103.
    Wirsching M, Stierlin H, Hoffmann Fet al.: Psychological identification of breast cancer patients before biopsy. J Psychosom Res 26: 1–10, 1982Google Scholar
  104. 104.
    Temoshok L, Fox BH: Coping styles and other psychosocial factors related to medical status and to prognosis in patients with cutaneous malignant melanoma. In: Fox BH, Newberry BH (eds) Impact of Psychoneurocrine System in Cancer and Immunity. CJ Hogrefe, Toronto, 1984, pp 86–146Google Scholar
  105. 105.
    Temoshok L: Personality, coping style, emotion and cancer: towards an intergrative model. Cancer Surveys 6: 545–567, 1987Google Scholar
  106. 106.
    Faragher EB, Cooper CL: Type A stress prone behavior and breast cancer. Psychol Med 20: 663–670, 1990Google Scholar
  107. 107.
    Hilakivi-Clarke LA, Arora PK, Sabol MBet al.: Alterations in behavior, steroid hormones and natural killer cell activity in male transgenic TGFα mice. Brain Res 588: 97–103, 1992Google Scholar
  108. 108.
    Hilakivi-Clarke LA, Arora PK, Clarke Ret al.: Opposing behavioral alterations in male and female transgenic TGFα mice: association with tumor susceptability. Br J Cancer 67: 1026–1030, 1993Google Scholar
  109. 109.
    Sandgren EP, Luetteke NC, Palmiter RDet al.: Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic mataplasia, and carcinoma of the breast. Cell 61: 1121–1135, 1990Google Scholar
  110. 110.
    Bates SE, Davidson NE, Valverius EMet al.: Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol 2: 543–555, 1988Google Scholar
  111. 111.
    Lippman ME: Psychosocial factors and the hormonal regulation of tumor growth. In: Levy SM (ed) Behavior and Cancer. Jossey-Bass, San Francisco, 1985, pp 134–147Google Scholar
  112. 112.
    Thomas L: On immunosurveillance in human cancer. Yale J Biol Med 55: 329–333, 1982Google Scholar
  113. 113.
    Rees R, Ali S: Antitumor lymphocyte responses. In: Hancock BW, Ward AW (eds) Immunology and Cancer. Martinus Nijhoff, Boston, 1985, pp 11–50Google Scholar
  114. 114.
    Bovbjerg D: Psychoneuroimmunology and cancer. In: Holland JC, Rowland JH (eds) Handbook of Psychooncology. Oxford University Press, New York, 1989, pp 727–734Google Scholar
  115. 115.
    Wheelock EF, Robinson MK: Endogenous control of the neoplastic process. Lab Invest 48: 120–139, 1983Google Scholar
  116. 116.
    Contreras OO, Stoliar A: Immunologic changes in human breast cancer. Eur J Gynecol Oncol 9: 502–514, 1988Google Scholar
  117. 117.
    Strayer DR, Carter WA, Mayberry SDet al.: Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with familial incidences of cancer. Cancer Res 44: 370–374, 1984Google Scholar
  118. 118.
    Levy SM, Herberman RB, Lippman Met al.: Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav Med Summer 17: 67–75, 1991Google Scholar
  119. 119.
    Pike MC, Krailo MD, Henderson BEet al.: Hormonal risk factors, breast tissue age and the age incidence of breast cancer. Nature 303: 767–769, 1983Google Scholar
  120. 120.
    Clarke R, Brünner N, Katzenellenbogen BSet al.: Progression from hormone dependent to hormone independent growth in MCF-7 human breast cancer cells. Proc Natl Acad Sci USA 86: 3649–3653, 1989Google Scholar
  121. 121.
    Holtkamp W, Nagel GA, Wander H-Eet al.: Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer. Int J Cancer 34: 323–328, 1984Google Scholar
  122. 122.
    Shiu RP, Murphy LG, Tsuyuki Det al.: Biological actions of prolactin in human breast cancer. Rec Prog Horm Res 43: 277–303, 1987Google Scholar
  123. 123.
    Love RR, Rose DR, Surawicz TSet al.: Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer. Cancer 68: 1401–1405, 1991Google Scholar
  124. 124.
    Bonneterre J, Peyrat JP, Beuscart Ret al.: Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer. J Steroid Biochem Mol Biol 37: 977–981, 1990Google Scholar
  125. 125.
    Manni A, Wright C, Davis Get al.: Promotion by prolactin of the growth of human breast neoplasmas culturedin vitro in the soft agar clonogenic assay. Cancer Res 46: 1669–1672, 1986Google Scholar
  126. 126.
    Ferguson DJP, Anderson TJ: Morphological evaluation of cell turnover in relation to the menstrual cycle in the resting human breast. Br J Cancer 44: 177–181, 1981Google Scholar
  127. 127.
    Kiecolt-Glaser J, Glaser R: Psychological influences on immunity. Psychosom 27: 621–624, 1986Google Scholar
  128. 128.
    Glaser R, Rice J, Speicher Cet al.: Stress depresses interferon production by leukocytes concomitant with a decrease in natural killer cell activity. Behav Neurosci 100: 675–678, 1986Google Scholar
  129. 129.
    Shavit Y, Terman GW, Martin Fet al.: Stress, opioid peptides, the immune system, and cancer. J Immunol 135: 834–837, 1987Google Scholar
  130. 130.
    Laudenslager M, Ryan S, Drugan Set al.: Coping and immune suppression: inescapable but not escapable shock suppresses lymphocyte proliferation. Science 221: 568–570, 1983Google Scholar
  131. 131.
    Irwin M, Daniels M, Weiner H: Immune and neuroendocrine changes during bereavement. Psych Clin North Am 449: 465, 1987Google Scholar
  132. 132.
    Helsing KJ, Szklo M: Mortality after bereavement. Am J Epi 114: 41–52, 1981Google Scholar
  133. 133.
    Stein M: Bereavement, depression, stress and immunity. In: Guillemin R (ed) Neural Modulation of Immunity. Raven Press, New York, 1985, pp 29–41Google Scholar
  134. 134.
    Stoll BA: Psycho-physiologic aspects of breast cancer. Eur J Cancer, suppl 1: 221–222, 1980Google Scholar
  135. 135.
    Gala RR: The physiology and mechanisms of the stressinduced changes in prolactin secretion in the rat. Life Sci 46: 1407–1420, 1990Google Scholar
  136. 136.
    Morishige WK, Rothchild I: A paradoncal inhibiting effect of ether on prolactin release in the rat: Comparison with effect of ether on GH and FSH. Neuroendocrinology 16: 95–107, 1974Google Scholar
  137. 137.
    Smith SW, Gala RR: Influence of restraint on plasma prolactin and corticosterone in female rats. J Endocrinol 74: 303–314, 1977Google Scholar
  138. 138.
    Manni A, Rainieri J, Arafah BMet al.: Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors. Cancer Res 42: 3492–3497, 1982Google Scholar
  139. 139.
    Mishell DR Jr: The pharmacological and metabolic effects of oral contraceptives. Int J Fertil 34 Suppl: 21–26, 1989Google Scholar
  140. 140.
    Orr TE, Mann DR: Effects of restraint stress on plasma LH and testosterone concentrations, Leydig cell LH/HCG receptors, andin vitro testicular steroidogenesis in adult rats. Horm Behav 24: 324–341, 1990Google Scholar
  141. 141.
    Mason JW, Taylor ED, Brady JVet al.: Urinary estrone, estradiol, and estriol responses to 72-hr avoidance sessions in the monkey. Physchosom Med 30: 696–709, 1968Google Scholar
  142. 142.
    Ballinger S: Stress as a factor in lowered estrogen levels in the early postmenopause. Ann N Y Acad Sci 592: 95–113, 1991Google Scholar
  143. 143.
    Jordan VC: The role of tamoxifen in the treatment and prevention of breast cancer. Curr Probl Cancer 16: 129–176, 1992Google Scholar
  144. 144.
    Ron IG, Inbar MJ, Barak Yet al.: Organic delusional syndrome associated with tamoxifen treatment. Cancer 69: 1415–1417, 1992Google Scholar
  145. 145.
    Bernardi M, Vergoni AV, Sandrini Met al.: Influence of ovariectomy, estradiol and progesterone on the behavior of mice in an experimental model of depression. Physiol Behav 45: 1067–1068, 1989Google Scholar
  146. 146.
    MacNiven E, DeCatanzaro D, Younglai EV: Chronic stress increases estrogen and other steroids in inseminated rats. Physiol Behav 52: 159–162, 1992Google Scholar
  147. 147.
    Vom Saal FS, Quadagno DH, Even MDet al.: Paradoxical effects of maternal stress on fetal steroids and postnatal reproductive traits in female mice from different intrauterine positions. Biol Reprod 43: 751–761, 1990Google Scholar
  148. 148.
    Morley JE, Benton D, Solomon GF: The role of stress and opioids as regulators of the immune system. In: McCubbin JA, Kaufmann PG, Nemeroff CB (eds) Stress, Neuropeptides, and Systemic Disease. Academic Press, San Diego, 1991, pp 221–231Google Scholar
  149. 149.
    Webster EL, Grigoriadis DE, Souza EB: Corticotrophinreleasing factor receptors in the brain-pituitary-immune axis. In: McCubbin JA, Kaufmann PG, Nemeroff CB (eds) Stress, Neuropeptides, and Systemic Disease. Academic Press, San Diego, 1991, pp 233–260Google Scholar
  150. 150.
    Bernton EW, Meltzer MS, Holaday JW: Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 239: 401–404, 1988Google Scholar
  151. 151.
    Besodowsky HO, del Ray A, Sorkin E: What do the immune system and the brain know about each other? Imm Today 4: 342–346, 1983Google Scholar
  152. 152.
    Yirmiya R, Ben-Eliyahu S, Liebeskind JCet al.: Modulation of immunity and neoplasia by neuropeptides released by stressors. In: McCubbin JA, Kaufmann PG, Nemeroff CB (eds) Stress, Neuropeptides and Systemic Disease. Academic Press, San Diego, 1991, pp. 261–286Google Scholar
  153. 153.
    Coffey RG, Hadden HW: Neurotransmitters, hormones, and cyclic nucleotides in lymphocyte regulation. Fed Proc 44: 112–117, 1985Google Scholar
  154. 154.
    Anisman H, Sklar LS: Stress provoked neurochemical changes in relation to neoplasia. In: Levy SM (ed) Biological Mediators of Behavior and Disease: Neoplasia. Elsevier Science Publishing Co, New York, 1982, pp 123–145Google Scholar
  155. 155.
    Takagi H, Sharp R, Hammermeister Cet al.: Molecular and genetic analysis of liver oncogenesis in transforming growth factor α transgenic mice. Cancer Res 52: 5171–5177, 1992Google Scholar
  156. 156.
    Miller AB: Role of nutrition in the etiology of breast cancer. Cancer 39: 2704–2798, 1977Google Scholar
  157. 157.
    Howe GR, Hirohata T, Hislop TGet al.: Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Nat Cancer Inst 82: 561–569, 1990Google Scholar
  158. 158.
    Dao TL, Chan PC: Effect of duration of high fat intake on enhancement of mammary carcinogenesis in rats. J Natl Cancer Inst 71: 201–205, 1983Google Scholar
  159. 159.
    Chan PC, Cohen LA: Effect of dietary fat, antiestrogen and antiprolactin on the development of mammary tumors in rats. J Natl Cancer Inst 52: 25–30, 1974Google Scholar
  160. 160.
    Freedman LS, Clifford C, Messina M: Analysis of dietary fat, calories, body weight, and the development of mammary tumors in rats and mice: a review. Cancer Res 50: 5710–5719, 1990Google Scholar
  161. 161.
    Welsch CW, O'Connor DH: Influence of dietary fat on developmental growth of the mammary gland in immature and mature female BALB/c mice. Cancer Res 49: 5999–6007, 1989Google Scholar
  162. 162.
    Willett W: The search for the causes of breast and colon cancer. Nature 338: 389–394, 1989Google Scholar
  163. 163.
    Willett WC, Hunter DJ, Stampfer MJet al.: Dietary fat and fiber in relation to risk of breast cancer. JAMA 268: 2037–2044, 1992Google Scholar
  164. 164.
    Marshall E: Search for a killer: focus shifts from fat to hormones. Science 259: 618–621, 1993Google Scholar
  165. 165.
    Cole P, MacMahon B: Oestrogen fractions during early reproductive life in the etiology of breast cancer. Lancet i: 604–606, 1969Google Scholar
  166. 166.
    de Waard F: Breast cancer incidence and nutritional status with particular reference to body weight and height. Cancer Res 35: 3351–3356, 1975Google Scholar
  167. 167.
    Micozzi MS: Nutrition, body size, and breast cancer. Yearbook of Phys Anthropol 128: 175–206, 1985Google Scholar
  168. 168.
    McGregor DH, Land CE, Choi K: Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki. J Natl Cancer Inst 59: 799–811, 1977Google Scholar
  169. 169.
    Boice JD, Stone BJ: Interaction between radiation and other breast cancer risk factors. In: Late Biological Effects of Ionizing Radiation. International Atomic Energy Agency, Vienna, 1978, pp 231–249Google Scholar
  170. 170.
    de Waard F, Trichopoulos D: A unifying concept of the aetiology of breast cancer. Int J Cancer 41:666–669, 1988Google Scholar
  171. 171.
    Walker BE: Tumors in female offspring of control and diethylstilbestrol-exposed mice fed high-fat diets. J Nat Cancer Inst 82: 50–54, 1990Google Scholar
  172. 172.
    Sonnenschein EG, Glickman LT, Goldschmidt MHet al.: Body conformation, diet, and risk of breast cancer in pet dogs: a case-control study. Am J Epidemiology 133: 694–703, 1991Google Scholar
  173. 173.
    Chu SY, Lee NC, Wingo PAet al.: Alcohol consumption and the risk of breast cancer. Am J Epidem 130: 867–877, 1989Google Scholar
  174. 174.
    Rohan TE, McMichael AJ: Alcohol consumption and risk of breast cancer. Int J Cancer 41: 695–699, 1988Google Scholar
  175. 175.
    Willett WC, Stampfer MJ, Colditz GAet al.: Moderate alcohol consumption and the risk of breast cancer. N Engl J Med 316: 1174–1180, 1987Google Scholar
  176. 176.
    Howe G, Rohan T, Decarli Aet al.: The association between alcohol and breast cancer risk: evidence from the combined analysis of six dietary case-control studies. Int J Cancer 47: 707–710, 1991Google Scholar
  177. 177.
    Van 't Veer P, Kok FJ, Hermus RJJet al.: Alcohol dose, frequency and age at first exposure in relation to the risk of breast cancer. Int J Epid 18: 511–517, 1989Google Scholar
  178. 178.
    Blot WJ: Alcohol and cancer. Cancer Res 52: 2119–2123, 1992Google Scholar
  179. 179.
    Schrauzer GN, McGinness JE, Ishmael Oet al.: Alcoholism and cancer. I. Effects of long-term exposure to alcohol on spontaneous mammary adeno carcinoma and prolactin levels in C3H/5+ mice. J Stud Alcohol 48: 240–246, 1979Google Scholar
  180. 180.
    Petitto JM, McIntyre TD, McRae BLet al.: Differential immune responsiveness in mouse lines selectively bred for high and low sensitivity to ethanol. Brain Behav Imm 4: 39–49, 1990Google Scholar
  181. 181.
    Schmale AH, Iker HP: The affect of hopelessness and the development of cancer. I. Identification of uterine cervical cancer. Psychosom Med 28: 714–721, 1966Google Scholar
  182. 182.
    Arnetz BB, Fjellner B: Psychological predictors of neuroendocrine responses to mental stress. J Psychosom Res 30: 297–305, 1986Google Scholar
  183. 183.
    Vogel WH, Bower DB: Stress, immunity, and cancer. In: Plotnikoff N, Murgo A, Faith Ret al. (eds) Stress and Immunity. CRC Press, Boca Raton, 1991, pp 493–507Google Scholar
  184. 184.
    Reynolds P, Kaplan GA: Social connections and risk for cancer: prospective evidence from the Alameda County study. Am J Epidem 1987Google Scholar
  185. 185.
    Stone EA, Platt JE: Brain adrenergic receptors and resistance to stress. Brain Res 237: 405–414, 1982Google Scholar
  186. 186.
    Pohorecky LA: The interaction of alcohol and stress. A review. Neurosci Biobehav Rev 5: 209–229, 1981Google Scholar
  187. 187.
    Hilakivi LA, Durcan MJ, Lister RG: Effects of ethanol on fight- or swim-stressed mice in Porsolt's swim test. Neuropsychopharmacology 2: 293–298, 1989Google Scholar
  188. 188.
    Hilakivi-Clarke LA, Lister RG: Social status and voluntary alcohol consumption in mice: interaction with stress. Psychopharmacology 108: 276–282, 1992Google Scholar

Copyright information

© Kluwer Academic Publishers 1993

Authors and Affiliations

  • Leena Hilakivi-Clarke
    • 1
    • 2
  • Julia Rowland
    • 2
  • Robert Clarke
    • 1
  • Marc E. Lippman
    • 1
  1. 1.Lombardi Cancer Research Center, Room S128Georgetown UniversityWashington DCUSA
  2. 2.Department of PsychiatryGeorgetown UniversityWashington, DCUSA

Personalised recommendations